- Lucigen特约代理_Lucigen
- Lucigen公司,LGC代理商,Lucigen经销商,LGC厂家直采,Lucigen官网...
- 请问大家中国北方工业公司(北京)笔试成绩出来 ...
- Lucigen 特约代理_文章
- epicentre中国代理,Lucigen中国代理,蓝景科信价格厂家:蓝景科信(...
- Frontiers | Limited Correlation of Shotgun Metagenomics...
- EconoTaq PLUS 2X Master Mix Lucigen
- 什么是lucigen产品 总代理中北林格为您略作讲解
- lucigen酶制剂产品分类及货号详情
- EconoTaq PLUS 2X Master Mix Lucigen
- 研究 STING 的 popular 工具
- 大肠杆菌电转化感受态细胞制备及转化方法 实验方法
Optimizedforhighyield,highqualitybiotin-aRNA
HighlyreproducIBLeamplification,labeling,andmicroarrayresults.- MultipleRNAsamplescanbeeasilyamplifiedandlabeledsimultaneously.
- LinearRNAamplificationprocesspreservesthetranscriptprofileofthesample.
- Simple,single-tube,6-hourprocedure.Preparebiotin-aRNAandbeginhybridizationthesameday.
- Biotin-aRNAproducedbythekitdetectsmoretranscripts(genes)thancompetitorkitsandshowedhighcorrelationwithMAQCTaqMan®data(Fig.1).
Applications
TheTargetAmp™1-RoundBiotin-aRNAAmplificationKit105*producesmicrogramamountsofbiotin-antisenseRNA(biotin-aRNA,alsocalledbiotin-cRNA)fromaslittleas25ngoftotalcellularRNA.Thekitprovidesallreagentsforthepreparationofbiotin-aRNA(exceptreversetranscriptaseandRNApurificationcolumns)andusesanimprovedEberwine-typelinearamplificationmethod1toachieveatleast5,000-foldamplificationofthepoly(A)RNApresentinatotalcellularRNAsample.Theentireprocedurecanbecompletedin1day.
Table1.ATargetAmp™Kit105reactionproduceshighyieldsofbiotin-aRNAfromaslittleas25ngofinputtotalRNA.Resultsrepresenttheaverageofmultipleexperiments.
| AmountofInputHeLaTotalRNA | Biotin-aRNAYieldfromHeLaTotalRNAa |
| 25ng | 4.1µg |
| 100ng | 13.7µg |
| 500ng | 64.9µg |
a.Approximately2%ofHeLatotalRNAispoly(A)RNA.
![]() | Figure1.CorrelationofexpressionratiosobtainedfromqPCRandfrommicroarrayshybridizedtoaRNApreparedwiththeTargetAmp™105kit.Xaxis,log2expressionratiosdeterminedfromHumanGenomeU133Plus2.0Arrays(Affymetrix)hybridizedtotargetspreparedbytheTargetAmp105kit;Yaxis,log2expressionratiosdeterminedbytheMAQC,usingTaqMan®assays.Thehighcorrelationobtained(r=0.936)indicatestheexcellentfidelityoftheamplificationprocess. |
References
- VanGelder,R.N.etal.(1990)Proc.Natl.Acad.Sci.USA87,1663.
*TargetAmp™aRNAAmplificationProductsarecoveredbyintellectualpropertylicensedtoEpicentreTechnologiesCorporationfromJohnson&JohnsonPharmaceuticalResearch&Development,L.L.C.,andbyintellectualpropertysublicensedtoEpicentreTechnologiesCorporationfromIncyteCorporation.
Forresearchuseonly.Someapplicationsinwhichthisproductmaybeusedmaybecoveredbypatentsorpatentapplicationsapplicableincertaincountries.Becausepurchaseofthisproductdoesnotincludealicensetoperformanypatentedapplication,usersofthisproductmayberequiredtoobtainalicense,dependingupontheparticularapplicationandcountryinwhichtheproductisused.



